KSPTN
OtherPreclinicalAlso known as: KSPTN peptide, Novel research peptide
KSPTN is a novel research peptide available from select peptide research vendors. Limited published literature is available.
Overview
At A Glance
Mechanism of action not fully characterized in available literature.
Overview
KSPTN is a novel research peptide available from select peptide research vendors. Limited published literature is available. It represents an emerging class of research compounds for which preclinical data is still being established.
Chemical Information
IUPAC Name
Not yet available
CAS Number
Not yet available
Molecular Formula
Not yet available
Molecular Mass
Not yet available
Chemical data is being compiled for this compound.
Dosing & Protocols
Unlock Dosing Protocols
Free account gets you:
- View beginner, intermediate & advanced protocols
- See weight-based dosing calculations
- Access cycle length & frequency data
2,800+ researchers already in
Research
Unlock Research Data
Free account gets you:
- Browse PubMed study summaries
- See clinical trial phases & results
- Access mechanism of action details
2,800+ researchers already in
Interactions
Interaction and contraindication data is being compiled for KSPTN. Check back soon.
General Safety Note
Always consult a qualified healthcare professional before combining research compounds. Interactions may exist that are not yet documented.
$29.00
up to $39.00
$3.9000
1
2
vial
| Vendor | Product | Form | Qty | Price | $/mg | Coupon | |
|---|---|---|---|---|---|---|---|
 |
KSPTN 5mg | vial | 1 vial● In Stock | $29.00BEST | $5.800 | — | |
|
|
KSPTN 10mg | vial | 1 vial● In Stock | $39.00VALUE | $3.900 | — |
Tracking since Apr 22, 2026 · 2 data points
Vendors Selling KSPTN
How we score these vendors
Every supplier above is graded 0–100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank.
Related Compounds
View AllAminotadalafil
OtherPreclinicalAminotadalafil is an unapproved research analog of tadalafil, the PDE5 inhibitor marketed under the brand name Cialis for erectile dysfunction and under Adcirca for pulmonary arterial hypertension.
B7-33
OtherPreclinicalB7-33 is a single-chain, 26-amino-acid peptide engineered as a functionally selective agonist of the relaxin family peptide receptor 1 (RXFP1), designed to recapitulate the therapeutic activity of human H2 relaxin — the endogenous peptide hormone that is naturally elevated during pregnancy and has broad cardioprotective, vasodilatory, and anti-fibrotic effects.
Melanotan I
OtherFDA ApprovedMelanotan I (afamelanotide) is a linear synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) with the substitution of norleucine at position 4 and D-phenylalanine at position 7.
PNC-27
OtherPreclinicalPNC-27 is a p53-derived peptide that selectively induces membranolysis in cancer cells.
Prostamax
OtherPreclinicalProstamax is a short synthetic peptide developed in Russia by Vladimir Khavinson and collaborators at the St.
RU-58841
OtherPreclinicalRU-58841 (also known as PSK-3841 or HMR-3841, and commonly written simply as RU in hair-loss forums) is a non-steroidal androgen receptor antagonist originally developed by Roussel Uclaf (later absorbed into Sanofi) in the late 1980s and early 1990s.
View Full Dosage Guide →
Protocols, calculator & safety for KSPTN
Research Score
0 PubMed studies
Quality Indicators
Data Completeness
63%Quick Facts
Half-Life
Unknown
Administration
Subcutaneous
Trial Phase
Preclinical
Safety Profile
Common Side Effects
- • No established adverse event profile
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Frequently Asked Questions
What is KSPTN used for in research?
KSPTN is a novel research peptide available from select peptide research vendors. Limited published literature is available. It represents an emerging class of research compounds for which preclinical data is still being established.
What forms does KSPTN come in?
KSPTN is available in vial form.
How much does KSPTN cost?
Prices start at $29.00 across 1 verified vendor.
How do I compare KSPTN vendors?
Compare prices, payment methods, shipping, and COA scores across 1 vendor.
Research Tools
Related Compounds
View AllAminotadalafil
OtherPreclinicalAminotadalafil is an unapproved research analog of tadalafil, the PDE5 inhibitor marketed under the brand name Cialis for erectile dysfunction and under Adcirca for pulmonary arterial hypertension.
B7-33
OtherPreclinicalB7-33 is a single-chain, 26-amino-acid peptide engineered as a functionally selective agonist of the relaxin family peptide receptor 1 (RXFP1), designed to recapitulate the therapeutic activity of human H2 relaxin — the endogenous peptide hormone that is naturally elevated during pregnancy and has broad cardioprotective, vasodilatory, and anti-fibrotic effects.
Melanotan I
OtherFDA ApprovedMelanotan I (afamelanotide) is a linear synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) with the substitution of norleucine at position 4 and D-phenylalanine at position 7.
PNC-27
OtherPreclinicalPNC-27 is a p53-derived peptide that selectively induces membranolysis in cancer cells.
Prostamax
OtherPreclinicalProstamax is a short synthetic peptide developed in Russia by Vladimir Khavinson and collaborators at the St.
RU-58841
OtherPreclinicalRU-58841 (also known as PSK-3841 or HMR-3841, and commonly written simply as RU in hair-loss forums) is a non-steroidal androgen receptor antagonist originally developed by Roussel Uclaf (later absorbed into Sanofi) in the late 1980s and early 1990s.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
